16 Jul 2018

Phenylpiracetam Carphedon (internationally called Fonturacetam, chemical - 4-phenylpyricetam) is a drug with nootropic effect, besides it has psychostimulating, anticonvulsant, antihypoxic and antihypertensive properties. It has an adaptogenic effect under various stress models.

Phenylpiracetam Carphedon prevents overloading of higher nervous activity during information overloads in experiments in higher animals, normalizes the daily biorhythm of the indicators of the sympathoadrenal system. It is a chemically improved formula of pyracetam.

Phenylpiracetam Carphedon in sport

Phenylpiracetam Carphedon has a clear activating effect, and therefore was listed in the list of banned substances by the World Anti-Doping Agency. So in 2006, Russian biathlete Olga Pyleva was disqualified for 2 years. In August 2008, another Russian athlete (run with obstacles) Roman Usov was disqualified.



According to the experience of using in sports, it is safe to say that this is one of the few drugs whose effect is really felt. Already on the second or third day of admission, there is a marked increase in endurance, physical activity and strength. It is recommended to take 3-7 days before the competition, in a dose of 200-500 mg per day. When recruiting muscle mass is undesirable, as phenotropic moderately reduces appetite and promotes weight loss.



It is worth noting that Phenylpiracetam Carphedon is extremely effective for increasing mental activity during preparation for exams or other heavy mental activity. Significantly reduces the need for sleep, improves the assimilation and processing of information. For these purposes is adopted by the instruction.

Phenylpiracetam Carphedon pharmachologic effect

Phenylpiracetam Carphedon - Nootropic drug, has a pronounced antiamnestic effect, has a direct activating effect on the integrative activity of the brain, promotes memory consolidation, improves concentration and mental activity, facilitates the learning process, increases the speed of information transfer between the cerebral hemispheres, increases the resistance of brain tissue to hypoxia and toxic impacts. It also has anticonvulsant and anxiolytic effects, regulates the processes of activation and inhibition of the central nervous system, improves mood. It has a positive effect on the metabolic processes and blood circulation of the brain, improves the regional blood flow in ischemic areas of the brain, stimulates redox processes, increases the energy potential of the organism due to better utilization of glucose. Increases the concentration of norepinephrine, dopamine and serotonin in the brain, does not affect the content of GABA, binds neither to GABAa nor to GABAb receptors, does not have a significant effect on spontaneous bioelectrical activity of the brain. Does not affect the respiratory and cardiovascular systems, shows an unexpressed diuretic effect, Phenylpiracetam Carphedon has anorexigenic activity in course use. The stimulating effect of the drug is manifested in the ability to exert a pronounced effect on motor reactions, in increasing physical performance, in pronounced antagonism to the catalepytic action of neuroleptics, and in the weakening of the expression of the hypnotic action of ethanol and hexenal. Phenylpiracetam Carphedon - psychostimulating action prevails in the ideatorial sphere. Has some analgesic effect, increasing the threshold of pain sensitivity. Phenylpiracetam Carphedon - adaptogenic action is manifested in increasing the body's resistance to stress in conditions of excessive mental and physical stress, fatigue, hypokinesia and immobilization, at low temperatures. Against the background of taking the drug, there is an increase in visual acuity, brightness and visual fields. Phenylpiracetam Carphedon improves blood circulation of the lower extremities. Stimulates the production of antibodies in response to the introduction of antigen, at the same time does not promote the development of immediate type hypersensitivity and does not change the skin allergic reaction caused by the introduction of a foreign protein. With the course application does not develop drug dependence, tolerance, withdrawal syndrome. The effect is manifested even when taking a single dose. Does not have a teratogenic, mutagenic, carcinogenic and embryotoxic effect. The toxicity of the drug is low, the lethal dose is 800 mg / kg.

Phenylpiracetam Carphedon Indications

CNS diseases associated with vascular diseases and metabolic disorders in the brain, intoxication (including post-traumatic conditions, chronic cerebrovascular insufficiency), accompanied by deterioration of intellectual-mnestic functions, decreased motor activity. Neurotic conditions manifested by lethargy, increased exhaustion, decreased psychomotor activity, impaired attention, memory impairment. Violation of the learning process. Depression of mild and moderate severity. Psycho-organic syndromes, manifested by intellectual-mnestic disorders and apatiko-bulimic phenomena; apatic conditions at a schizophrenia. Convulsive syndrome. Obesity (alimentary-constitutional genesis). Prevention of hypoxia, increased resistance to stress, correction of the functional state of the organism in extreme conditions of professional activity with the goal of preventing the development of fatigue and increasing mental and physical performance, correcting the daily biorhythm, inversion of the "sleep-wake" cycle. Chronic alcoholism (in order to reduce the phenomena of asthenia, depression, intellectual-mnestic disorders).

Phenylpiracetam Carphedon Contraindications

Hypersensitivity, pregnancy, lactation, children's age.C with caution. Heavy organic diseases of the liver and kidneys, severe arterial hypertension, atherosclerosis, panic attacks in the anamnesis, acute psychotic conditions that occur with psychomotor agitation (risk of worsening anxiety, panic, hallucinations and delirium), allergic reactions to drugs from the group of pyrrolidone.



Phenylpiracetam Carphedon Side effects

Insomnia (in case of taking the drug later than 15 hours). In the first 1-3 days: psychomotor agitation, hyperemia of the skin, sensation of heat, increased AD. Overdose. Treatment is symptomatic.



Phenylpiracetam Carphedon Dosing and Administration

Inside, right after eating. The average single dose is 150 mg (100-250 mg), the average daily dose is 250 mg (200-300 mg), the maximum daily dose is 750 mg. The daily dose is divided into 2 divided doses. Duration of treatment - from 2 weeks to 3 months. The average duration of treatment is 30 days. If necessary, a second course is possible after 1 month. To improve performance - 100-200 mg once in the morning for 2 weeks (for athletes - 3 days). Alimentary-constitutional obesity: 100-200 mg once a day in the morning hours for 30-60 days.



Phenylpiracetam Carphedon special instructions

It is not recommended to take the drug after 15 hours. In case of excessive psychoemotional exhaustion against the background of chronic stress and fatigue, chronic insomnia, a single dose of the drug in the first day can cause a sharp need for sleep, therefore it is recommended for patients on out-patient treatment to start treatment on non-working days.